Cargando…
The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China
The New Chinese Diabetes Risk Score (NCDRS) is one of the recommended tools for screening undiagnosed type 2 diabetes in China. However, its performance in detecting undiagnosed diabetes needs to be verified in different community populations. Also, it is unknown whether NCDRS can be used in detecti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210548/ https://www.ncbi.nlm.nih.gov/pubmed/32405505 http://dx.doi.org/10.1155/2020/7463082 |
_version_ | 1783531296187744256 |
---|---|
author | Mao, Tao Chen, Jiayan Guo, Haijian Qu, Chen He, Chu Xu, Xuepeng Yang, Guoping Zhen, Shiqi Li, Xiaoning |
author_facet | Mao, Tao Chen, Jiayan Guo, Haijian Qu, Chen He, Chu Xu, Xuepeng Yang, Guoping Zhen, Shiqi Li, Xiaoning |
author_sort | Mao, Tao |
collection | PubMed |
description | The New Chinese Diabetes Risk Score (NCDRS) is one of the recommended tools for screening undiagnosed type 2 diabetes in China. However, its performance in detecting undiagnosed diabetes needs to be verified in different community populations. Also, it is unknown whether NCDRS can be used in detecting prediabetes. In the present study, we aimed to evaluate the performance of NCDRS in detecting undiagnosed diabetes and prediabetes among the community residents in eastern China. We applied NCDRS in 7675 community residents aged 18-65 years old in Jiangsu Province. The results showed that the participants with undiagnosed diabetes reported the highest NCDRS value, followed by those with prediabetes (P < 0.001). The best cut-off points of NCDRS for detecting undiagnosed diabetes and prediabetes were 27 (with a sensitivity of 78.0% and a specificity of 57.7%) and 27 (with a sensitivity of 66.0% and a specificity of 62.9%). The AUCs of NCDRS for identifying undiagnosed diabetes and prediabetes were 0.749 (95% CI: 0.739~0.759) and 0.694 (95% CI: 0.683~0.705). These results demonstrate the excellent performance of NCDRS in screening undiagnosed diabetes in the community population in eastern China and further provide evidence for using NCDRS in detecting prediabetes. |
format | Online Article Text |
id | pubmed-7210548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-72105482020-05-13 The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China Mao, Tao Chen, Jiayan Guo, Haijian Qu, Chen He, Chu Xu, Xuepeng Yang, Guoping Zhen, Shiqi Li, Xiaoning J Diabetes Res Research Article The New Chinese Diabetes Risk Score (NCDRS) is one of the recommended tools for screening undiagnosed type 2 diabetes in China. However, its performance in detecting undiagnosed diabetes needs to be verified in different community populations. Also, it is unknown whether NCDRS can be used in detecting prediabetes. In the present study, we aimed to evaluate the performance of NCDRS in detecting undiagnosed diabetes and prediabetes among the community residents in eastern China. We applied NCDRS in 7675 community residents aged 18-65 years old in Jiangsu Province. The results showed that the participants with undiagnosed diabetes reported the highest NCDRS value, followed by those with prediabetes (P < 0.001). The best cut-off points of NCDRS for detecting undiagnosed diabetes and prediabetes were 27 (with a sensitivity of 78.0% and a specificity of 57.7%) and 27 (with a sensitivity of 66.0% and a specificity of 62.9%). The AUCs of NCDRS for identifying undiagnosed diabetes and prediabetes were 0.749 (95% CI: 0.739~0.759) and 0.694 (95% CI: 0.683~0.705). These results demonstrate the excellent performance of NCDRS in screening undiagnosed diabetes in the community population in eastern China and further provide evidence for using NCDRS in detecting prediabetes. Hindawi 2020-04-29 /pmc/articles/PMC7210548/ /pubmed/32405505 http://dx.doi.org/10.1155/2020/7463082 Text en Copyright © 2020 Tao Mao et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mao, Tao Chen, Jiayan Guo, Haijian Qu, Chen He, Chu Xu, Xuepeng Yang, Guoping Zhen, Shiqi Li, Xiaoning The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China |
title | The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China |
title_full | The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China |
title_fullStr | The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China |
title_full_unstemmed | The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China |
title_short | The Efficacy of New Chinese Diabetes Risk Score in Screening Undiagnosed Type 2 Diabetes and Prediabetes: A Community-Based Cross-Sectional Study in Eastern China |
title_sort | efficacy of new chinese diabetes risk score in screening undiagnosed type 2 diabetes and prediabetes: a community-based cross-sectional study in eastern china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210548/ https://www.ncbi.nlm.nih.gov/pubmed/32405505 http://dx.doi.org/10.1155/2020/7463082 |
work_keys_str_mv | AT maotao theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT chenjiayan theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT guohaijian theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT quchen theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT hechu theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT xuxuepeng theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT yangguoping theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT zhenshiqi theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT lixiaoning theefficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT maotao efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT chenjiayan efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT guohaijian efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT quchen efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT hechu efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT xuxuepeng efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT yangguoping efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT zhenshiqi efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina AT lixiaoning efficacyofnewchinesediabetesriskscoreinscreeningundiagnosedtype2diabetesandprediabetesacommunitybasedcrosssectionalstudyineasternchina |